Ningbo First Hospital participated in the research and development of the "National Weights" orthopedic surgery robot
Participated in the development of the fourth generation orthopedic surgery robot Ningbo First Hospital is the only unit in the province In the future, Ningbo orthopedic patients are expected to have domestic orthopedic robots operating at their doorsteps. The reporter learned from the First Hospital of the city yesterday that the hospital, as one of the 10 major participating units, participated in the national key research and development project: the development of multi-indication orthopedic surgery robot products. "Today is a very important day for the Department of Orthopaedics of the First Hospital of Ningbo City. Participating in the national key research and development projects, the pressure is big, and the confidence is full!" Recently, a WeChat of the Department of Orthopaedics of the First Hospital of Ningbo City, Xia Dongdong, attracted many praises. Not long ago, the national key R&D plan with a budget of more than 90 million yuan was held in Yantai, Shandong Province. The First Hospital of Ningbo is the only participating unit in the province and will cooperate with and participate in the design and development of the latest generation of orthopedic machines and clinical application research. The other participating units of this project are “big coffee in the industryâ€, including Beijing Jishuitan Hospital, Beijing University of Aeronautics and Astronautics, Southern Medical University, and the People's Liberation Army General Hospital. A new generation of domestic orthopedic surgery robots is the "national heavy weapon" being developed. It is understood that the national "13th Five-Year Plan" clearly lists "surgical robots" as the key development of robot equipment in the "high-end equipment innovation development project." Wang Wei, director of the Department of Orthopaedics of the First Hospital of Ningbo, said that advanced surgical robots have been monopolized by foreign manufacturers. Such as the well-known "Da Vinci" surgical robot in the industry, in a small glass bottle, for a grape "skin" suture surgery, is the industry leader. Nowadays, the research and development of domestic surgical robots is in the process of catching up quickly, and is committed to achieving “curve overtakingâ€. Robots have less trauma and less bleeding Orthopedic surgery robot has broad application prospects The reason why the country attaches so much importance to the development of orthopedic surgery robots is because its application prospects are very broad. Wang Wei introduced that orthopedic diseases have now ranked the fourth in the world for human death. Surgery is an important treatment for bone trauma. There are more than 20 million cases of bone trauma every year in China, and 79.35% of them require surgery. However, because traditional orthopedic surgery relies too much on doctors' experience, it is traumatic, low in accuracy, and has many complications, which causes great suffering for patients. It is urgent to innovate treatment concepts, means and equipment. Minimally invasive treatment has become the development of orthopedic clinical treatment. trend. The first hospital in Ningbo City, orthopedic doctor, Xia Dongdong introduced that the third-generation domestic orthopedic surgery robot called “TianzhuoTM†has been used in clinical practice for a period of time, and thousands of patients have successfully completed the operation. At present, the Scorpio TM orthopedic surgery robot is the only orthopaedic surgical robot system in the world that can perform the whole segmental spine, pelvis and extremity fractures. Practice has shown that compared with traditional surgery, the use of orthopedic surgery robot surgery, intraoperative radiation reduction of more than 70%, minimally invasive surgery, small incision, operation time and intraoperative blood loss significantly reduced. "For example, in a complicated pelvic fracture operation, multiple nails need to be punched in the operation, and the patient will leave a wound of ten or twenty centimeters. If it is a robot, only a few centimeters or two of the wound is needed, and the wound is wounded. Small, less bleeding." Xia Dongdong introduced, not only that, surgical robot positioning is more accurate, and traditional surgery requires continuous X-ray fluoroscopy, because the surgical robot can be three-dimensional positioning, the damage to patients and doctors is also smaller. In general, orthopedic surgery robots can achieve more personalized surgical design and simulation, provide surgical positioning accuracy beyond the limits of human hand, effectively reduce the risk of complications, improve the quality of surgery, shorten the postoperative rehabilitation cycle, and reduce the overall medical treatment cost. The Harvard postdoctoral introduction introduced by the hospital is responsible for project execution. The goal of the four-generation domestic orthopedic surgery robot is to be smarter. The first hospital of Ningbo City participated in the research and development of domestic robots. It was the talents introduced by the hospital in August last year, Harvard postdoctoral summer and winter. The Ningbo-born "Super Bull Baby" graduated from medical school and continued his studies. He eventually became a postdoctoral fellow at Harvard Medical School. After he became a student, he refused to retain the American tutor, gave up the opportunity to stay in Shanghai, and returned to work in his hometown of Ningbo. Xia Dongdong is also the first postdoctoral fellow of Harvard Medical School introduced by the medical unit of our city. "Technology has progressed very quickly. Now we have heard that robotic orthopedic surgery may be a myth, but in the case of complex orthopedic surgery, the application of robots is inevitable." Xia Dongdong said that because of the high precision of surgical robots, The characteristics of small trauma, currently in hospitals in the United States, orthopedic surgery robots are more common, and there are multiple models and brands of orthopedic robots to choose from. "This time in Yantai hospital, I also observed two operations with three generations of domestic orthopedic surgery robots." Xia Dongdong said that he found that the third-generation domestic orthopedic surgery robots and foreign products are already on the same level, with an error of only 0. .8 mm, negligible, but needs to be improved in terms of intelligence. It is understood that the same type of Israeli and French orthopedic surgery robots have errors of 1.5 mm and 2 mm, respectively. Xia Dongdong said that although the clinical application of the third-generation orthopedic surgery robot is very successful, it still has the problem of single function and narrow operation range. The development goal of the fourth-generation domestic orthopedic surgery robot is to apply more surgery, and the level of intelligence is higher. . Xia Dongdong boldly predicted that in the next 20 years, Ningbo people will find that orthopaedic robots will be as common as going to the hospital for CT examination, because it is good for patients. "Complex orthopedic surgery requires high medical experience for doctors. Like some complicated orthopedic fracture operations, doctors need more than ten years of clinical experience to be competent." Director Wang Wei introduced that the Department of Orthopaedics of Ningbo First Hospital is also the Department of Orthopaedics of Ningbo City. The Institute currently has about 2,000 orthopedic operations per year. With orthopedic surgery robots, doctors can design surgical procedures, and robots can perform surgery more minimally and accurately. This will not require many years of clinical experience. Ordinary orthopedic surgeons can work with robots to complete difficult operations. (China Ningbo Network) Dingmin Pharmaceutical supply Efinaconazole API and Efinaconazole Intermediates with high purity and best price. The main products CAS No are as follows:164650-44-6, 127000-90-2, 133775-25-4, 159635-49-1, 144230-50-2. Sample can be sent if you request. Cas 241479-67-4 ,Efinaconazole Intermediates,Methylenepiperidine Hydrochloride Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd , https://www.dingminpharma.com
Welcome to do business with us. Please email to us directly.